TEVA Stock Ownership Activity

TEVA PHARMACEUTICAL-SP ADR 13F holders

3 value investing gurus have made changes to the TEVA PHARMACEUTICAL-SP ADR (TEVA) position according to the gurus' latest SEC quarterly report(s). The number of TEVA shares has been increased by 1, decreased by 2 super investor(s).

Which gurus or hedge funds are buying TEVA now?

According to the latest SEC filing(s) TEVA PHARMACEUTICAL-SP ADR (TEVA) has been bought by David Einhorn - Greenlight Capital (added shares +44.24%).

To see more about who is investing in TEVA PHARMACEUTICAL-SP ADR (TEVA), please go to the TEVA ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2018 Q1 (3 results)
Bill Miller
Miller Value Partners
+325.29%
+1,678,860
+1.23%
1.61%
Warren Buffett
Berkshire Hathaway
+114.77%
+21,663,989
+0.20%
0.37%
Ronald Muhlenkamp
Muhlenkamp & Co
-100.00%
-700
-0.00%
0.00%
Current price: $15.08 11.76% AVG reported price*: $17.09
2017 Q4 (4 results)
Warren Buffett
Berkshire Hathaway
buy
+18,875,721
+0.19%
0.19%
Bill Miller
Miller Value Partners
buy
+516,112
+0.42%
0.42%
David Abrams
Abrams Capital Management
-8.70%
-1,880,763
-1.20%
12.60%
Francis Chou
Chou Associates Management
-97.03%
-490,000
-4.05%
0.12%
Current price: $15.08 20.40% AVG reported price*: $18.95
2017 Q3 (2 results)
David Abrams
Abrams Capital Management
buy
+21,623,886
+14.85%
14.85%
Ronald Muhlenkamp
Muhlenkamp & Co
-99.34%
-105,805
-0.60%
0.00%
Current price: $15.08 13.19% AVG reported price*: $17.37
2017 Q2 (3 results)
Francis Chou
Chou Associates Management
+134.88%
+290,000
+3.03%
5.28%
Ronald Muhlenkamp
Muhlenkamp & Co
-0.13%
-140
-0.00%
1.16%
David Tepper
Appaloosa Management
-100.00%
-2,175,000
-1.04%
0.00%
Current price: $15.08 54.69% AVG reported price*: $33.28
2017 Q1 (3 results)
Francis Chou
Chou Associates Management
buy
+215,000
+2.33%
2.33%
Ronald Muhlenkamp
Muhlenkamp & Co
-55.54%
-133,244
-1.39%
1.11%
David Tepper
Appaloosa Management
-56.96%
-2,878,000
-1.61%
0.00%
Current price: $15.08 53.00% AVG reported price*: $32.09
2016 Q4 (3 results)
David Tepper
Appaloosa Management
buy
+5,053,000
+3.38%
3.38%
Ronald Muhlenkamp
Muhlenkamp & Co
+36.48%
+64,119
+0.78%
2.90%
Ole Andreas Halvorsen
Viking Global Investors
-100.00%
-19,684,219
-4.12%
0.00%
Current price: $15.08 58.40% AVG reported price*: $36.25
2016 Q3 (2 results)
Ronald Muhlenkamp
Muhlenkamp & Co
-0.50%
-885
-0.02%
3.09%
Ole Andreas Halvorsen
Viking Global Investors
-29.03%
-8,052,436
-1.60%
0.00%
Current price: $15.08 67.22% AVG reported price*: $46.01
2016 Q2 (2 results)
Ronald Muhlenkamp
Muhlenkamp & Co
-0.29%
-505
-0.01%
3.49%
Ole Andreas Halvorsen
Viking Global Investors
-15.88%
-5,234,967
-1.12%
5.92%
Current price: $15.08 69.98% AVG reported price*: $50.23
2016 Q1 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
+31.66%
+7,927,847
+1.87%
7.77%
Ronald Muhlenkamp
Muhlenkamp & Co
+0.12%
+205
+0.00%
3.90%
Current price: $15.08 71.82% AVG reported price*: $53.51
2015 Q4 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
+182.26%
+16,171,125
+4.00%
6.20%
Current price: $15.08 77.03% Reported price*: $65.64
2015 Q3 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
buy
+8,872,650
+1.92%
1.92%
Ronald Muhlenkamp
Muhlenkamp & Co
+0.02%
+40
+0.00%
3.07%
Current price: $15.08 73.29% AVG reported price*: $56.46
2015 Q2 (2 results)
Ronald Muhlenkamp
Muhlenkamp & Co
+0.12%
+205
+0.00%
2.36%
Ole Andreas Halvorsen
Viking Global Investors
-100.00%
-228,600
-0.05%
0.00%
Current price: $15.08 74.48% AVG reported price*: $59.10
2015 Q1 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
buy
+228,600
+0.06%
0.00%
Ronald Muhlenkamp
Muhlenkamp & Co
+0.18%
+325
+0.00%
2.33%
Current price: $15.08 75.79% AVG reported price*: $62.30
2014 Q4 (1 result)
Ronald Muhlenkamp
Muhlenkamp & Co
-0.27%
-470
-0.01%
2.05%
Current price: $15.08 73.78% Reported price*: $57.51
2014 Q2 (1 result)
Ronald Muhlenkamp
Muhlenkamp & Co
+0.81%
+1,415
+0.01%
1.65%
Current price: $15.08 71.23% Reported price*: $52.42
2014 Q1 (1 result)
Ronald Muhlenkamp
Muhlenkamp & Co
-0.51%
-900
-0.01%
1.65%
Current price: $15.08 71.46% Reported price*: $52.84
2013 Q4 (2 results)
Ronald Muhlenkamp
Muhlenkamp & Co
+3.74%
+6,355
+0.05%
1.25%
Ravenel Boykin Curry IV
Eagle Capital Management
-100.00%
-22,400
-0.00%
0.00%
Current price: $15.08 62.38% AVG reported price*: $40.08
2013 Q3 (2 results)
Ronald Muhlenkamp
Muhlenkamp & Co
+0.19%
+325
+0.00%
1.29%
David Abrams
Abrams Capital Management
-100.00%
-2,561,269
-7.86%
0.00%
Current price: $15.08 60.08% AVG reported price*: $37.78
2013 Q2 (3 results)
Ravenel Boykin Curry IV
Eagle Capital Management
buy
+22,400
+0.00%
0.00%
David Abrams
Abrams Capital Management
buy
+2,561,269
+5.81%
0.00%
Ronald Muhlenkamp
Muhlenkamp & Co
buy
+169,660
+1.40%
1.40%
Current price: $15.08 61.53% AVG reported price*: $39.20
41 of 90

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.